Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment,Alimentary Pharmacology & Therapeutics

当前位置： X-MOL 学术 › Aliment. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2021-11-13 , DOI: 10.1111/apt.16697
Chen-Hua Liu, Cheng-Yuan Peng, Wei-Yu Kao, Sheng-Shun Yang, Yu-Lueng Shih, Chin-Lin Lin, Meng-Kun Tsai, Chih-Yuan Lee, Chun-Chao Chang, Jo-Hsuan Wu, Chun-Jen Liu, Tung-Hung Su, Tai-Chung Tseng, Pei-Jer Chen, Jia-Horng Kao

Data are limited regarding the risk of hepatitis C virus (HCV) reinfection after treatment-induced sustained virologic response (SVR) in patients on haemodialysis.

中文翻译：